Like many other LSDs and leukodystrophies, RNASET2‐deficient leukoencephalopathy affects patients during the early years of life, suggesting a fetal initial insult (Henneke et al., 2009; Rutherford & Hamilton, 2019). This evidence concerns the gene RNASET2 and leukodystrophy.